Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Íñigo-Marco

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Personalized Medicine|July 2, 2021
Olfactory Bulb Proteomics Reveals Widespread Proteostatic Disturbances in Mixed Dementia and Guides for Potential Serum Biomarkers to Discriminate Alzheimer Disease and Mixed Dementia PhenotypesMercedes Lachén-Montes, Ignacio Íñigo-Marco, Paz Cartas-Cejudo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2017
E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregationIgnacio Íñigo-Marco, Miguel Valencia, Laura Larrea, et al.
Biomolecules|August 23, 2020
CB2 Receptors and Neuron-Glia Interactions Modulate Neurotoxicity Generated by MAGL InhibitionEstefania Rojo-Bustamante, Ignacio Íñigo-Marco, Miguel Angel Abellanas, et al.
Aging|May 13, 2023
Proteostatic modulation in brain aging without associated Alzheimer's disease-and age-related neuropathological changesPol Andrés-Benito, Ignacio Íñigo-Marco, Marta Brullas, et al.
Neurobiology of Disease|January 29, 2020
N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicityRodrigo Vinueza-Gavilanes, Ignacio Íñigo-Marco, Laura Larrea, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Personalized Medicine|July 2, 2021
Olfactory Bulb Proteomics Reveals Widespread Proteostatic Disturbances in Mixed Dementia and Guides for Potential Serum Biomarkers to Discriminate Alzheimer Disease and Mixed Dementia PhenotypesMercedes Lachén-Montes, Ignacio Íñigo-Marco, Paz Cartas-Cejudo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2017
E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregationIgnacio Íñigo-Marco, Miguel Valencia, Laura Larrea, et al.
Biomolecules|August 23, 2020
CB2 Receptors and Neuron-Glia Interactions Modulate Neurotoxicity Generated by MAGL InhibitionEstefania Rojo-Bustamante, Ignacio Íñigo-Marco, Miguel Angel Abellanas, et al.
Aging|May 13, 2023
Proteostatic modulation in brain aging without associated Alzheimer's disease-and age-related neuropathological changesPol Andrés-Benito, Ignacio Íñigo-Marco, Marta Brullas, et al.
Neurobiology of Disease|January 29, 2020
N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicityRodrigo Vinueza-Gavilanes, Ignacio Íñigo-Marco, Laura Larrea, et al.
Pageof 1